Aammaad Shams - Aug 1, 2022 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Role
Chief Accounting Officer
Signature
/s/ Jonathan Weinberg, Attorney-in-fact
Stock symbol
EVH
Transactions as of
Aug 1, 2022
Transactions value $
$0
Form type
4
Date filed
8/4/2022, 05:50 PM
Previous filing
Mar 3, 2022
Next filing
Mar 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVH Class A Common Stock Award $0 +17.2K +87.83% $0.00 36.9K Aug 1, 2022 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units granted to Mr. Shams pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
F2 Securities vest at a rate of 34% on August 1, 2023, and 33% on August 1, 2024, and August 1, 2025.
F3 Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.